Incyte Clinical related costs increased by 1.0% to $177.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 33.9%, from $132.73M to $177.70M. Over 4 years (FY 2021 to FY 2025), Clinical related costs shows an upward trend with a 12.6% CAGR.
other_accrued_clinical_related_costs_current| Q4 '21 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $109.49M | $152.76M | $130.57M | $117.42M | $137.78M | $100.28M | $109.62M | $94.55M | $105.68M | $120.56M | $132.45M | $132.73M | $146.29M | $157.68M | $175.93M | $177.70M |
| QoQ Change | — | +39.5% | -14.5% | -10.1% | +17.3% | -27.2% | +9.3% | -13.7% | +11.8% | +14.1% | +9.9% | +0.2% | +10.2% | +7.8% | +11.6% | +1.0% |
| YoY Change | — | — | +19.3% | — | — | -34.4% | -16.0% | -19.5% | -23.3% | +20.2% | +20.8% | +40.4% | +38.4% | +30.8% | +32.8% | +33.9% |